Literature DB >> 6174107

Rapid syncytium formation induced by Moloney murine sarcoma virus in 3T3/NIH cells and its delay by mouse interferon.

M Aboud, M Huleihel.   

Abstract

Moloney murine sarcoma virus (MSV) clone 124 was found to induce rapid syncytium formation upon infection of 3T3/NIH at a high multiplicity of infection. This effect became apparent, by light microscopy, within 1 to 2 hours, whereas by scanning electron microscopy, clusters of 4 to 25 cells were seen in their initial steps of syncytium formation within 20 to 30 minutes after virus addition. It appeared that the cell fusion was initiated by connection between the cells through virus bound to their surface. After a few more hours several neighbouring syncytia fused into giant cells containing over a hundred nuclei. Though MSV (124) stocks contained also some MLV it appeared that the syncytium inducing activity was related to the MSV particles. MLV particles were not only incapable to induce syncytium formation, they even interfered with this activity of MSV. The MSV-induced cell fusion required the adsorption of intact virions, but was independent on protein synthesis. Mouse interferon remarkably reduced the rate of syncytium development.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6174107     DOI: 10.1007/BF01315004

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  36 in total

1.  POLYKARYOCYTOSIS INDUCED BY ROUS SARCOMA VIRUS IN CHICK FIBROBLASTS.

Authors:  E MOSES; A KOHN
Journal:  Exp Cell Res       Date:  1963-10       Impact factor: 3.905

2.  Preliminary biochemical characterization of the factors(s) responsible for herpesvirus-induced exogenous fusion.

Authors:  D B Levitan; H A Blough
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

3.  Adsorption, penetration, and uncoating of murine leukemia virus studied by using its reverse transcriptase.

Authors:  M Aboud; R Shoor; S Salzberg
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

4.  Fusion of a Rous sarcoma virus transformed human cell line, KC, by RD-114 virus.

Authors:  K H Rand; C W Long
Journal:  J Gen Virol       Date:  1973-12       Impact factor: 3.891

5.  Syncytial assay for the putative human C-type virus, RD-114, utilizing human cells transformed by Rous sarcoma virus.

Authors:  K H Rand; C Long
Journal:  Nat New Biol       Date:  1972-12-06

6.  Mycoplasma contamination of animal cell cultures: a simple, rapid detection method.

Authors:  E M Levine
Journal:  Exp Cell Res       Date:  1972-09       Impact factor: 3.905

7.  Studies on bovine lymphosarcoma: formation of syncytia and detection of virus particles in mixed-cell cultures.

Authors:  F Cornefert-Jensen; W C Hare; N D Stock
Journal:  Int J Cancer       Date:  1969-07-15       Impact factor: 7.396

8.  Inhibition of Mason-Pfizer monkey virus-induced syncytium formation in normal human cells by homologous interferon.

Authors:  S Chatterjee; E Hunter
Journal:  Virology       Date:  1980-07-30       Impact factor: 3.616

9.  Induction of syncytia by the bovine C-type leukemia virus.

Authors:  C A Diglio; J F Ferrer
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

10.  Suppressive effects of interferon on syncytium formation by RD-114 virus in human transformed cells.

Authors:  Y Tomita; T Kuwata
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

View more
  2 in total

1.  Stimulation of virus production and induction of self-syncytium formation in human T-cell leukemia virus type I- and type II-infected T cells by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  M Wolfson; M Lev; I Avinoah; Z Malik; M Löchelt; R M Flügel; A Dombrovski; M Aboud
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

2.  Suppression of murine leukemia virus-mediated 3Y1 cell fusion by expression of mouse MHC class I.

Authors:  N Momozaki; H Ogura; J Miyazaki; S Matsuhashi; K Joh; G Kimura; K Tabuchi; K Hori
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.